sorafenib has been researched along with withaferin a in 3 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (withaferin a) | Trials (withaferin a) | Recent Studies (post-2010) (withaferin a) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 590 | 22 | 454 |
Protein | Taxonomy | sorafenib (IC50) | withaferin a (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.585 | |
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.047 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.047 | |
Transcription factor p65 | Homo sapiens (human) | 0.047 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cohen, MS; Cohen, SM; Mukerji, R; Samadi, AK; Timmermann, BN | 1 |
Chakraborti, A; Kanthaje, S; Kaur, H; Kaur, R; Makol, A; Sharma, S | 1 |
Duan, J; Fan, L; Jiang, B; Liu, S; Tan, Y; Yin, H; Zhang, Y; Zhao, X | 1 |
3 other study(ies) available for sorafenib and withaferin a
Article | Year |
---|---|
A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Carcinoma; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Humans; Inhibitory Concentration 50; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Withanolides | 2012 |
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Hepatocellular; Cell Survival; Chromatography, High Pressure Liquid; Down-Regulation; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Liver Neoplasms; Proteomics; Sorafenib; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vimentin; Withanolides | 2020 |
Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Ferroptosis; Humans; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; NF-E2-Related Factor 2; Sorafenib | 2023 |